Cargando…

In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, the causative agent of coronavirus disease (COVID-19)) has caused relatively high mortality rates in humans throughout the world since its first detection in late December 2019, leading to the most devastating pandemic of the current centu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shehata, Mahmoud M., Mahmoud, Sara H., Tarek, Mohammad, Al-Karmalawy, Ahmed A., Mahmoud, Amal, Mostafa, Ahmed, M. Elhefnawi, Mahmoud, Ali, Mohamed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540548/ https://www.ncbi.nlm.nih.gov/pubmed/34684763 http://dx.doi.org/10.3390/molecules26206182

Ejemplares similares

Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
por: Mahmoud, Amal, et al.
Publicado: (2021)

Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

Targeting SARS-CoV-2 endoribonuclease: a structure-based virtual screening supported by in vitro analysis
por: Ibrahim, Ibrahim M., et al.
Publicado: (2022)

In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2021)

Scrutinizing the Feasibility of Nonionic Surfactants to Form Isotropic Bicelles of Curcumin: a Potential Antiviral Candidate Against COVID-19
por: Mahmoud, Dina B., et al.
Publicado: (2021)

In silico identification of potential key regulatory factors in smoking-induced lung cancer
por: El-aarag, Salem A., et al.
Publicado: (2017)

Pimenta dioica (L.) Merr. Bioactive Constituents Exert Anti-SARS-CoV-2 and Anti-Inflammatory Activities: Molecular Docking and Dynamics, In Vitro, and In Vivo Studies
por: El Gizawy, Heba A., et al.
Publicado: (2021)

Immunogenicity and effectiveness of a bivalent influenza A/H1N2 vaccine strain against seasonal human influenza A viruses in mice
por: Kamel, Mina Nabil, et al.
Publicado: (2022)

Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2
por: Kandeil, Ahmed, et al.
Publicado: (2020)

Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome
por: El-aarag, Salem A., et al.
Publicado: (2022)

Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: In silico and in vitro studies
por: Mahmoud, Dina B., et al.
Publicado: (2021)

In vitro and in silico characterization of alkaline serine protease from Bacillus subtilis D9 recovered from Saudi Arabia
por: Mahmoud, Amal, et al.
Publicado: (2021)

In Silico Analysis of MicroRNA Expression Data in Liver Cancer
por: Abu-Shahba, Nourhan, et al.
Publicado: (2023)

A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice
por: Shehata, Mahmoud M., et al.
Publicado: (2019)

Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt
por: Kandeil, Ahmed, et al.
Publicado: (2020)

Eryngium creticum L.: Chemical Characterization, SARS-CoV-2 Inhibitory Activity, and In Silico Study
por: Elsbaey, Marwa, et al.
Publicado: (2022)

Strong Inhibitory Activity and Action Modes of Synthetic Maslinic Acid Derivative on Highly Pathogenic Coronaviruses: COVID-19 Drug Candidate
por: Soltane, Raya, et al.
Publicado: (2021)

In-silico screening of naturally derived phytochemicals against SARS-CoV Main protease
por: Mostafa, Islam, et al.
Publicado: (2021)

Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study
por: Ibrahim, Mahmoud A.A., et al.
Publicado: (2021)

Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducers
por: El-Kalyoubi, Samar, et al.
Publicado: (2023)

Naturally occurring plant-based anticancerous candidates as prospective ABCG2 inhibitors: an in silico drug discovery study
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2022)

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science
por: Mostafa, Ahmed, et al.
Publicado: (2020)

Evaluation of calpain T-cell epitopes as vaccine candidates against experimental Leishmania major infection: a pilot study
por: Brakat, Reham, et al.
Publicado: (2022)

Carotane sesquiterpenes from Ferula vesceritensis: in silico analysis as SARS-CoV-2 binding inhibitors
por: Mohamed, Tarik A., et al.
Publicado: (2020)

Co-regulatory Network of Oncosuppressor miRNAs and Transcription Factors for Pathology of Human Hepatic Cancer Stem Cells (HCSC)
por: Mohamed, Rania Hassan, et al.
Publicado: (2019)

Identification and characterization of adipose surface epitopes
por: Onogi, Yasuhiro, et al.
Publicado: (2020)

Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
por: Kutkat, Omnia, et al.
Publicado: (2022)

In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives
por: Sohail, Muhammad Saqib, et al.
Publicado: (2021)

Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis
por: Yazdani, Zahra, et al.
Publicado: (2020)

Spiroindole-containing compounds bearing phosphonate group of potential M(pro)-SARS-CoV-2 inhibitory properties
por: Bekheit, Mohamed S., et al.
Publicado: (2023)

Multi-Subunit SARS-CoV-2 Vaccine Design Using Evolutionarily Conserved T- and B- Cell Epitopes
por: Akbay, Burkitkan, et al.
Publicado: (2021)

Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV
por: Shehata, Mahmoud M., et al.
Publicado: (2019)

Chetomin, a SARS-CoV-2 3C-like Protease (3CL(pro)) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2023)

In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing
por: Abdelkader, Ahmed, et al.
Publicado: (2022)

Immunoinformatics prediction of potential B-cell and T-cell epitopes as effective vaccine candidates for eliciting immunogenic responses against Epstein–Barr virus
por: Olotu, Fisayo A., et al.
Publicado: (2021)

MysiRNA-Designer: A Workflow for Efficient siRNA Design
por: Mysara, Mohamed, et al.
Publicado: (2011)

Synthesis and in Silico Investigation of Organoselenium-Clubbed Schiff Bases as Potential M(pro) Inhibitors for the SARS-CoV-2 Replication
por: Shaaban, Saad, et al.
Publicado: (2023)

Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2023)

Assessment of corneal endothelial cell parameters using specular microscopy in previously infected SARS-CoV-2 patients
por: Elshalkami, Mohamed Anis, et al.
Publicado: (2023)

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
por: Kandeil, Ahmed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fgbr5is1pvvb2h15f9grf5qrq7